Healthcare

• Telix Pharmaceuticals (ASX: TLX) has established itself as one of the ASX’s most commercially active radiopharmaceutical companies, with a track record of high-profile deals and licensing agreements.

• Clarity Pharmaceuticals (ASX:CU6) surged 15.70% to $2.10on 29 June 2026, among the day's notable healthcare movers.

• Avecho Biotechnology (ASX:AVE) delivered a significant market catalyst with encouraging interim Phase III insomnia trial data

• Echo IQ (ASX: EIQ) is gaining attention as artificial intelligence in healthcare becomes one of the ASX’s most prominent investment themes

• ASX: EMD is advancing its depression treatment program with clinical data increasingly central to the company’s growth narrative.

• 4DMedical (ASX:4DX) has developed proprietary lung imaging technology that provides dynamic, functional assessments of respiratory health

• Six ASX-listed healthcare companies are benefiting from long-term demand driven by ageing populations and healthcare innovation.